Literature DB >> 18426277

Histological diagnosis of atypical Takayasu arteritis using percutaneous transluminal atherectomy.

Ulrich Beschorner1, Heike Goebel, Aljoscha Rastan, Sebastian Sixt, Thomas Zeller.   

Abstract

PURPOSE: To describe the use of percutaneous directional atherectomy to aid in the diagnosis of atypical Takayasu arteritis in the lower limb vessels. CASE REPORT: In a 24-year-old woman with severe peripheral artery disease (Rutherford-Becker category 5), imaging showed bilateral occlusion of the superficial femoral arteries (SFA), but no lesions of the proximal or supra-aortic vessels. The right SFA was treated first; after guidewire passage through the occlusion, 7 passes of the SilverHawk Peripheral Atherectomy Catheter debulked the lesion, followed by balloon angioplasty. Catheter biopsy showed inflammatory infiltrates consistent with Takayasu arteritis.
CONCLUSION: Percutaneous transluminal atherectomy is not only an interventional device but also a diagnostic tool and can be used to distinguish between inflammatory and atherosclerotic lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18426277     DOI: 10.1583/07-2317.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  3 in total

1.  Transcriptional regulation of beta2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma.

Authors:  Brian L Stauffer; Erich J Kushner; Ted Wulfman; Thomas Zeller; Rebecca Sobus; Christian M Westby
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

Review 2.  [Imaging techniques in the evaluation of primary large vessel vasculitides: part 1: angiography, interventional therapy, and magnetic resonance imaging].

Authors:  M Both; B Nölle; C von Forstner; F Moosig; W L Gross; M Heller
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

3.  [Large-vessel vasculitis. Imaging and interventional therapy].

Authors:  M Both; F Moosig; W L Gross; M Heller
Journal:  Radiologe       Date:  2009-10       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.